Physicians

LaserACE® Global Medical Director

amh

"My decision on being involved as an investigator with LaserACE® technology is threefold: (1) the ability to restore dynamic accommodation without compromise to the refractive state of the eye; (2) the lack of visual axis compromise; (3) the market potential for such a procedure on emmetropic presbyopes and/or past monofocal IOL patients is immense.  I truly am excited about continuing to pave the way for my patients to see beyond their imagination by using a technology that rejuvenates the eye’s natural power."

Mitchell A. Jackson, MD
JacksonEye
Lake Villa, Illinois
This email address is being protected from spambots. You need JavaScript enabled to view it.

LaserACE® Clinical Study Principal Investigators

Prof. David Hui-Kang Ma, MD,PHD
Principal Investigator - Taiwan

Prof. Dr. Chi-Chin Sun MD, PhD
Principal Investigator

Xingtao Zhou, MD, PHD.
Principal Investigator - China (Shanghai)

Professor Li Ying MD, PhD
Principal Investigator - China (Beijing)

Professor Qinmei Wang, MD, OD
Principal Investigator - China (Wenzhou)

Associate Professor Shihao Chen MD,MSc,OD
Principal Investigator - China (Wenzhou)

Professor Kazuo Tsubota
Principal Investigator - Japan (Tokyo)

Guillermo Ocampo, MD
Principal Investigator - Mexico (Mexico City)

Professor Sunil Shah, MD, PhD
Principal Investigator - United Kingdom

Robert T. Ang, MD
Principal Investigator - Philippines

Note: LaserACE® is not yet FDA approved or available in the United States. It is currently in clinical trials only in select areas outside of the United States.

logomobilesidebar